Matthew P Travers
Examiner (ID: 7633, Phone: (571)272-3218 , Office: P/3726 )
Most Active Art Unit | 3726 |
Art Unit(s) | 3726 |
Total Applications | 808 |
Issued Applications | 496 |
Pending Applications | 76 |
Abandoned Applications | 235 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14685677
[patent_doc_number] => 20190241953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => BARCODED CIRCULAR LIBRARY CONSTRUCTION FOR IDENTIFICATION OF CHIMERIC PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 16/384013
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384013
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/384013 | BARCODED CIRCULAR LIBRARY CONSTRUCTION FOR IDENTIFICATION OF CHIMERIC PRODUCTS | Apr 14, 2019 | Abandoned |
Array
(
[id] => 16837787
[patent_doc_number] => 20210145799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => PHARMACEUTICAL COMBINATION PRODUCTS COMPRISING A HISTONE DEACETYLASE (HDAC) INHIBITOR AND A TLR7 AGONIST AND/OR TLR8 AGONIST FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/047529
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 890
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047529
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047529 | PHARMACEUTICAL COMBINATION PRODUCTS COMPRISING A HISTONE DEACETYLASE (HDAC) INHIBITOR AND A TLR7 AGONIST AND/OR TLR8 AGONIST FOR THE TREATMENT OF CANCER | Apr 14, 2019 | Pending |
Array
(
[id] => 16837826
[patent_doc_number] => 20210145838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => SELECTIVE PDE4D INHIBITORS AGAINST DEMYELINATING DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/044894
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044894 | SELECTIVE PDE4D INHIBITORS AGAINST DEMYELINATING DISEASES | Apr 3, 2019 | Abandoned |
Array
(
[id] => 14578295
[patent_doc_number] => 20190216756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => ORGANIC ACIDS AS AGENTS TO DISSOLVE CALCIUM MINERALS IN PATHOLOGICAL CALCIFICATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/366094
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16366094
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/366094 | ORGANIC ACIDS AS AGENTS TO DISSOLVE CALCIUM MINERALS IN PATHOLOGICAL CALCIFICATION AND USES THEREOF | Mar 26, 2019 | Abandoned |
Array
(
[id] => 17178578
[patent_doc_number] => 11155813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Semi-random barcodes for nucleic acid analysis
[patent_app_type] => utility
[patent_app_number] => 16/295548
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 17713
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295548
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295548 | Semi-random barcodes for nucleic acid analysis | Mar 6, 2019 | Issued |
Array
(
[id] => 16572137
[patent_doc_number] => 10894048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-19
[patent_title] => Antitumor drug for intermittent administration of FGFR inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/274573
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28371
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274573
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/274573 | Antitumor drug for intermittent administration of FGFR inhibitor | Feb 12, 2019 | Issued |
Array
(
[id] => 14692073
[patent_doc_number] => 20190245152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/268713
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16268713
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/268713 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | Feb 5, 2019 | Abandoned |
Array
(
[id] => 17681167
[patent_doc_number] => 11365408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Library preparation
[patent_app_type] => utility
[patent_app_number] => 16/268971
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6072
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16268971
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/268971 | Library preparation | Feb 5, 2019 | Issued |
Array
(
[id] => 16727762
[patent_doc_number] => 20210094909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => 3-(BENZYLAMINO)-4-(CYCLOHEXYLAMINO)-N-(2-(PIPERAZIN-1-YL)ETHYL)BENZENESULFONAMIDE DERIVATIVES AND RELATED FERROSTATIN-1 ANALOGUES AS CELL DEATH INHIBITORS FOR TREATING E.G. STROKE
[patent_app_type] => utility
[patent_app_number] => 16/967871
[patent_app_country] => US
[patent_app_date] => 2019-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967871
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967871 | 3-(benzylamino)-4-(cyclohexylamino)-n-(2-(piperazin-1-yl)ethyl)benzenesulfonamide derivatives and related ferrostatin-1 analogues as cell death inhibitors for treating e.g. stroke | Feb 4, 2019 | Issued |
Array
(
[id] => 14990947
[patent_doc_number] => 20190314431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Method of Discovery of Potential Bioactive Compounds in Herbals by Regrouping after Chromatography
[patent_app_type] => utility
[patent_app_number] => 16/258500
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16258500
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/258500 | Method of Discovery of Potential Bioactive Compounds in Herbals by Regrouping after Chromatography | Jan 24, 2019 | Abandoned |
Array
(
[id] => 16711838
[patent_doc_number] => 20210078985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/961690
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961690
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961690 | COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | Jan 10, 2019 | Abandoned |
Array
(
[id] => 14277887
[patent_doc_number] => 20190136228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => REAGENTS, KITS AND METHODS FOR MOLECULAR BARCODING
[patent_app_type] => utility
[patent_app_number] => 16/246195
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 299
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246195
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/246195 | Reagents, kits and methods for molecular barcoding | Jan 10, 2019 | Issued |
Array
(
[id] => 14948201
[patent_doc_number] => 10435357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-08
[patent_title] => Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures
[patent_app_type] => utility
[patent_app_number] => 16/239069
[patent_app_country] => US
[patent_app_date] => 2019-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11309
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16239069
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/239069 | Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures | Jan 2, 2019 | Issued |
Array
(
[id] => 16816788
[patent_doc_number] => 11001594
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Heterocyclic modulators of HIF activity for treatment of disease
[patent_app_type] => utility
[patent_app_number] => 16/229015
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 42607
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16229015
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/229015 | Heterocyclic modulators of HIF activity for treatment of disease | Dec 20, 2018 | Issued |
Array
(
[id] => 16315884
[patent_doc_number] => 20200294622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => Subtyping of TNBC And Methods
[patent_app_type] => utility
[patent_app_number] => 16/765462
[patent_app_country] => US
[patent_app_date] => 2018-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765462
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/765462 | Subtyping of TNBC And Methods | Dec 2, 2018 | Abandoned |
Array
(
[id] => 14342931
[patent_doc_number] => 20190153438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => METHODS AND COMPOSITIONS FOR PREPARING POLYNUCLEOTIDE LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 16/191337
[patent_app_country] => US
[patent_app_date] => 2018-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16191337
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/191337 | METHODS AND COMPOSITIONS FOR PREPARING POLYNUCLEOTIDE LIBRARIES | Nov 13, 2018 | Abandoned |
Array
(
[id] => 14310303
[patent_doc_number] => 20190144855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => FOCUSED ACOUSTICS MEDIATED NUCLEIC ACID LIGATION
[patent_app_type] => utility
[patent_app_number] => 16/182740
[patent_app_country] => US
[patent_app_date] => 2018-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16182740
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/182740 | FOCUSED ACOUSTICS MEDIATED NUCLEIC ACID LIGATION | Nov 6, 2018 | Abandoned |
Array
(
[id] => 16806021
[patent_doc_number] => 20210128574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => NOVEL USES
[patent_app_type] => utility
[patent_app_number] => 16/182572
[patent_app_country] => US
[patent_app_date] => 2018-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16182572
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/182572 | NOVEL USES | Nov 5, 2018 | Abandoned |
Array
(
[id] => 13987347
[patent_doc_number] => 20190062831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => DIFFERENTIAL TAGGING OF RNA FOR PREPARATION OF A CELL-FREE DNA/RNA SEQUENCING LIBRARY
[patent_app_type] => utility
[patent_app_number] => 16/177105
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16177105
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/177105 | Differential tagging of RNA for preparation of a cell-free DNA/RNA sequencing library | Oct 30, 2018 | Issued |
Array
(
[id] => 14213729
[patent_doc_number] => 20190119249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/163829
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16163829
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/163829 | Methods and compounds for restoring mutant p53 function | Oct 17, 2018 | Issued |